TELA Bio, Inc.
TELA
$1.27
-$0.03-2.31%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 3.18% | -7.81% | 18.91% | 5.10% | 3.22% |
| Total Depreciation and Amortization | 23.67% | 26.36% | 25.25% | 6.21% | 2.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,279.41% | 1,298.61% | -98.53% | -108.94% | -109.99% |
| Change in Net Operating Assets | -65.13% | 35.77% | -145.29% | 9.23% | 76.76% |
| Cash from Operations | 20.78% | 15.41% | -1.81% | -10.61% | -3.93% |
| Capital Expenditure | 43.52% | 10.38% | -61.87% | -105.75% | -54.93% |
| Sale of Property, Plant, and Equipment | 45,233.33% | 45,233.33% | 45,233.33% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -190.91% | -196.60% | -- | 636.60% | 636.60% |
| Cash from Investing | -99.32% | -102.54% | 843.07% | 406.34% | 375.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8,659.55% | -8.09% | -6.72% | -98.85% | -99.39% |
| Repurchase of Common Stock | 39.66% | 35.50% | -27.68% | 28.17% | 30.82% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29,682.64% | -7.89% | -6.94% | -99.63% | -99.82% |
| Foreign Exchange rate Adjustments | -2,046.67% | -183.98% | -82.93% | -173.30% | -84.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 122.03% | -21.88% | 19.42% | -1,122.03% | -202.57% |